Davendra Sohal, MD of Cleveland Clinic discusses the impact of perioperative chemotherapy on management of resectable pancreatic cancer. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
TPS4152: Perioperative mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma